Výsledky vyhledávání - "Pamela A. Moise"

Akademický článek

Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)

Autor: Karri A. Bauer, Laura A. Puzniak, Kalvin C. Yu, Kenneth P. Klinker, Janet A. Watts, Pamela A. Moise, Lyn Finelli, Vikas Gupta

Publikováno v: BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-11 (2023)

Abstract Background Antibiotic usage and antibiotic resistance (ABR) patterns changed during the COVID-19 pandemic. Inadequate empiric antibiotic therapy (IET) is a significant public health problem and contributes to ABR. We evaluated factors associ

Externí odkaz: https://doaj.org/article/bd79a4f4ac744a1ab3a466f90d277b7c

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

Autor: Michael A. Pfaller, Dee Shortridge, Kelly A. Harris, Mark W. Garrison, C. Andrew DeRyke, Daryl D. DePestel, Pamela A. Moise, Helio S. Sader

Publikováno v: International Journal of Infectious Diseases, Vol 112, Iss , Pp 321-326 (2021)

ABSTRACT: Objectives: To report on the activity of ceftolozane-tazobactam and comparators against Pseudomonas aeruginosa isolates collected from hospitalized patients with pneumonia in US intensive care units (ICUs) between 2015 and 2018. Activity ag

Externí odkaz: https://doaj.org/article/cf72f849d8a4498eace2fdbed29e04ca

Zobrazit plný text záznamu

A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic

Autor: Karri A Bauer, Laura A Puzniak, Kalvin C Yu, Kenneth P Klinker, Janet A Watts, Pamela A Moise, Lyn Finelli, ChinEn Ai, Vikas Gupta

Publikováno v: Open forum infectious diseases. 9(11)

Background Antibacterial therapy is frequently used in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) without evidence of bacterial infection, prompting concerns about increased antimicrobial resistance (AMR). We evaluated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dad6642803f56ce9031aa114843ed42
https://pubmed.ncbi.nlm.nih.gov/36381612

Zobrazit plný text záznamu

Plný text ve formátu HTML

Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020

Autor: Laura A Puzniak, Karri A. Bauer, Latha Vankeepuram, Pamela A. Moise, Kalvin Yu, Gang Ye, Lyn Finelli, Carisa De Anda, Vikas Gupta

Publikováno v: Open Forum Infectious Diseases

Background Increased utilization of antimicrobial therapy has been observed during the coronavirus disease 2019 pandemic. We evaluated hospital outcomes based on the adequacy of antibacterial therapy for bacterial pathogens in US patients. Methods Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a799d343b832d393426f857d3302aa
https://doi.org/10.1093/ofid/ofab232

Zobrazit plný text záznamu

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015-2018

Autor: Pamela A. Moise, Dee Shortridge, C Andrew DeRyke, Michael A. Pfaller, Helio S. Sader, Kelly A Harris, Daryl D. DePestel, Mark W Garrison

Publikováno v: International Journal of Infectious Diseases, Vol 112, Iss, Pp 321-326 (2021)

Objectives: To report on the activity of ceftolozane-tazobactam and comparators against Pseudomonas aeruginosa isolates collected from hospitalized patients with pneumonia in US intensive care units (ICUs) between 2015 and 2018. Activity against all

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3ebdcada3721d719f87d5707fa1736
https://pubmed.ncbi.nlm.nih.gov/34597763

Zobrazit plný text záznamu

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

Autor: Vikas Gupta, Kalvin Yu, Karri A. Bauer, Carisa De Anda, Aryana Sepassi, Pamela A. Moise, Latha Vankeepuram, Laura A Puzniak, Lyn Finelli

Publikováno v: BMC infectious diseases, vol 21, iss 1
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)

Background Past respiratory viral epidemics suggest that bacterial infections impact clinical outcomes. There is minimal information on potential co-pathogens in patients with coronavirus disease-2019 (COVID-19) in the US. We analyzed pathogens, anti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fbf62752807bedc231f6f50248ed668
https://escholarship.org/uc/item/7g78g292

Zobrazit plný text záznamu

Collective assessment of antimicrobial susceptibility among the most common Gram-negative respiratory pathogens driving therapy in the ICU

Autor: Jacqueline Pavia, Meredith Hackel, Wei-Ting Chen, C Andrew DeRyke, Irina Alekseeva, Brune Akrich, Mary Motyl, Diego Lopez, Brandon Palermo, Pamela A. Moise, Marcela Gonzalez

Publikováno v: JAC-Antimicrobial Resistance

Objectives To describe the pathogen predominance and to evaluate the probability of covering the most common Gram-negative pathogens collectively in both empirical and early adjustment prescribing scenarios in ICU patients with respiratory infections

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d243b7080e8fb1cf6cf9414b166d9c1a
http://europepmc.org/articles/PMC8209971

Zobrazit plný text záznamu

373. Comparison of the Epidemiology and Pathogens Cultured from Patients Hospitalized with SARS-CoV-2 Positive versus SARS-CoV-2 Negative in the US: A Multicenter Evaluation

Autor: Pamela A. Moise, P. Parikh, C. De Anda, Vikas Gupta, Karri A. Bauer, Kalvin Yu, Lynn Finelli, Laura A Puzniak, Latha Vankeepuram

Publikováno v: Open Forum Infectious Diseases

Background Past experiences with viral epidemics have indicated an increased risk for bacterial, fungal, or other viral secondary or co-infections due to patient characteristics, healthcare exposures and biological factors. It is important to underst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3920eda84011bd36089f790dea4ae94d
http://europepmc.org/articles/PMC7777625

Zobrazit plný text záznamu

379. Epidemiology of Antimicrobial Use Among SARS-CoV-2 Positive and Negative Admissions in the US: A Multicenter Evaluation

Autor: Pamela A. Moise, P. Parikh, Vikas Gupta, C. De Anda, Latha Vankeepuram, Lynn Finelli, Karri A. Bauer, Kalvin Yu, Laura A Puzniak

Publikováno v: Open Forum Infectious Diseases

Background SARS-CoV-2, a novel coronavirus, emerged in Wuhan, China in December of 2019, and became a pandemic. Increases in bacterial/fungal co-infections have occurred during influenza pandemics and early data from this pandemic indicate high utili

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed062867d17515c68740ff7db2106c48
http://europepmc.org/articles/PMC7777122

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání